Panel Discussion: Translating Modality Into Value for Patients to Establish Clearly Defined Clinical Objectives
Time: 1:50 pm
day: CONFERENCE DAY ONE
Details:
- Building on the industry’s failures to re-evaluate how to select and measure the right clinical outcome
- Steering the direction of research to acquire robust data that can illustrate clinical translatability and expedite discovery towards Phase I of clinical trials
- Positioning patients at the heart of the modality to demonstrate its viability, thereby eliminating the need for a cost-risk analysis
